Wikidata

(Q40874901)

English

Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms

scientific article

In more languages

Statements

title
Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
10849376
retrieved
24 September 2017
publication date
1 June 2000
1 reference
stated in
Europe PubMed Central
PubMed ID
10849376
retrieved
24 September 2017
page(s)
634-641
1 reference
stated in
Europe PubMed Central
PubMed ID
10849376
retrieved
24 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40874901&oldid=1909404205"